Zsa Zsa Weerts

A putative anti-inflammatory role for TRPM8 in IBS 115 5 References 1. Hughes PA, Zola H, Penttila IA, et al. Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms? Am J Gastroenterol 2013;108: 1066-1074. 2. Palsson OS, Whitehead W, Tornblom H, et al. Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom. Gastroenterology 2020;158: 1262-1273 e1263. 3. Canavan C, West J, Card T. Review article: the economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther 2014; 40:1023-1034. 4. Mearin F, Lacy BE, Chang L, et al. Bowel Disorders. Gastroenterology 2016; DOI 10.1053/j.gastro.2016.02.031. 5. Weerts Z, Masclee AAM, Witteman BJM, et al. Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome. Gastroenterology 2020;158: 123-136. 6. Black CJ, Moayyedi P, Quigley EMM, et al. Peppermint Oil in Irritable Bowel Syndrome. Gastroenterology 2020;159: 395-396. 7. Black CJ, Yuan Y, Selinger CP, et al. Efficacy of soluble fibre, antispasmodic drugs, and gut- brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol 2020;5: 117-131. 8. Eccles R. Menthol and related cooling compounds. J Pharm Pharmacol 1994; 46: 618-630. 9. Stein RJ, Santos S, Nagatomi J, et al. Cool (TRPM8) and hot (TRPV1) receptors in the bladder and male genital tract. J Urology 2004;172:1175-1178. 10. Harrington AM, Hughes PA, Martin CM, et al. A novel role for TRPM8 in visceral afferent function. Pain 2011;152:1459-1468. 11. Beckers AB, Weerts Z, Helyes Z, Masclee AAM, Keszthelyi D. Review article: transient receptor potential channels as possible therapeutic targets in irritable bowel syndrome. Aliment Pharmacol Ther 2017; 46: 938-952. 12. Khalil M, Babes A, Lakra R, et al. Transient receptor potential melastatin 8 ion channel in macrophages modulates colitis through a balance-shift in TNF-alpha and interleukin-10 production. Mucosal Immunol 2016;9:1500- 1513. 13. de Jong PR, Takahashi N, Peiris M, et al. TRPM8 on mucosal sensory nerves regulates colitogenic responses by innate immune cells via CGRP. Mucosal Immunol 2015;8:491-504. 14. Ramachandran R, Hyun E, Zhao L, et al. TRPM8 activation attenuates inflammatory responses in mouse models of colitis. Proc Natl Acad Sci U S A 2013;110:7476-7481. 15. Henstrom M, Hadizadeh F, Beyder A, et al. TRPM8 polymorphisms associated with increased risk of IBS-C and IBS-M. Gut 2017;66:1725-1727. 16. Collin M, McGovern N, Haniffa M. Human dendritic cell subsets. Immunology 2013;140: 22-30. 17. del Rio ML, Bernhardt G, Rodriguez-Barbosa JI, et al. Development and functional specialization of CD103+ dendritic cells. Immunol Rev 2010;234: 268-281. 18. Hughes PA, Harrington AM, Castro J, et al. Sensory neuro-immune interactions differ between irritable bowel syndrome subtypes. Gut 2013;62:1456-1465. 19. Casado-Bedmar M, Keita AV. Potential neuro- immune therapeutic targets in irritable bowel syndrome. Therap Adv Gastroenterol 2020;13:1756284820910630. 20. Burns G, Carroll G, Mathe A, et al. Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review. Am J Gastroenterol 2019;114:429-436. 21. Russo F, Chimienti G, Clemente C, D'Attoma B, Linsalata M, Orlando A, De Carne M, Cariola F, Semeraro FP, Pepe G, Riezzo G. Adipokine profile in celiac patients: differences in comparison with patients suffering from diarrhea-predominant IBS and healthy subjects. Scand J Gastroenterol. 2013;48(12):1377-85. 22. Grover M, Herfarth H, Drossman DA. The functional-organic dichotomy: postinfectious irritable bowel syndrome and inflammatory bowel disease-irritable bowel syndrome. Clin Gastroenterol Hepatol 2009;7:48-53. 23. McGuire C, Boundouki G, Hockley JRF, et al. Ex vivo study of human visceral nociceptors. Gut 2018;67:86-96.